PharmX Technologies Limited (ASX:PHX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1000
0.00 (0.00%)
Jul 29, 2026, 9:59 AM AEST

PharmX Technologies Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-0.93-0.26-1.77-1.050.251.09
Depreciation & Amortization
0.490.410.380.520.890.87
Other Amortization
0.90.870.821.661.310.95
Loss (Gain) From Sale of Assets
0000.02--0.01
Loss (Gain) From Sale of Investments
------1.73
Stock-Based Compensation
0.220.220.020.060.02-
Other Operating Activities
10.350.650.561.591.542.91
Change in Accounts Receivable
0.020.02-1.33-0.07-0.223.66
Change in Inventory
-0.03-0.03-0.03-0.010.03
Change in Accounts Payable
-10.28-10.2811.07-0.73-1.04-4.79
Change in Unearned Revenue
0.020.02-9.468.18-0.17-0.13
Change in Income Taxes
0.520.520.78-0.11-00.15
Change in Other Net Operating Assets
-0.01-0.010.1-0.071.080.33
Operating Cash Flow
1.01-8.133.2110.943.283.16
Operating Cash Flow Growth
---70.71%233.56%3.76%756.91%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-0.03-0.03-0.02-0.09-0.1-0.3
Cash Acquisitions
------2.1
Sale (Purchase) of Intangibles
-1.83-1.72-1.57-3.27-3.88-3.79
Other Investing Activities
-0.21.063.33-0.210.34-
Investing Cash Flow
-2.06-0.71.75-3.57-3.64-6.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Long-Term Debt Repaid
--0.12-0.12-0.31-0.32-0.4
Net Debt Issued (Repaid)
-0.19-0.12-0.12-0.31-0.32-0.4
Issuance of Common Stock
-----8.94
Common Dividends Paid
---4.49---0.9
Other Financing Activities
-0.03-0.02-0.02-0.01-0.04-0.46
Financing Cash Flow
-0.22-0.14-4.62-0.33-0.367.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash Flow
-1.27-8.960.337.05-0.724.16

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
0.98-8.163.1910.863.192.86
Free Cash Flow Growth
---70.63%240.94%11.29%1243.66%
Free Cash Flow Margin
12.79%-108.38%39.40%177.23%59.15%24.10%
Free Cash Flow Per Share
0.00-0.010.010.020.010.01
Levered Free Cash Flow
-1.23-9.025.9-1.08-1.863.05
Unlevered Free Cash Flow
-1.21-95.93-1.05-1.863.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
0.030.020.020.010.030.03
Cash Income Tax Paid
--0.86-1.66-1.55-1.56-1.7
Change in Working Capital
-10.02-10.021.337.41-0.39-0.93